首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

2021709

穿戴式心電圖監測設備市場預測至2034年：按設備類型、監測方法、技術、應用、最終用戶和地區分類的全球分析

Wearable Cardiac Monitoring Devices Market Forecasts to 2034 - Global Analysis By Device Type, Monitoring Type, Technology, Application, End User and By Geography

出版日期: 2026年04月17日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，全球穿戴式心電圖監測設備市場預計到 2026 年將達到 140 億美元，並在預測期內以 21% 的複合年成長率成長，到 2034 年將達到 650 億美元。

穿戴式心電圖監測設備是攜帶式、佩戴於身上的技術，能夠持續追蹤心率、心率和電活動等心臟參數。這些設備包括智慧型手錶、貼片和攜帶式心電圖儀，可提供即時數據和警報。它們有助於早期發現心臟異常，輔助慢性疾病管理，並提高患者參與度。與行動應用程式和醫療保健系統的整合，使臨床醫生能夠進行遠端監測。人們對心血管健康的日益關注以及穿戴式科技的進步，正在推動這些設備在全球的普及。

心血管疾病盛行率增加

隨著心律不整、心臟衰竭和冠狀動脈疾病的日益普遍，對持續且易於使用的監測解決方案的需求也日益成長。這些設備能夠提供心率、心率和其他生命徵象的即時訊息，從而實現異常情況的早期發現。其便攜性和易用性使其適用於醫院和居家照護。醫療保健專業人員正擴大採用穿戴式裝置來改善患者預後並減少再入院率。隨著心血管疾病成為全球性的健康挑戰，對穿戴式監測解決方案的需求預計將持續強勁。

電池續航力和設備精度限制

持續監測需要設備長期運作，但電池容量的限制往往導致頻繁充電。此外，數據準確性的波動，尤其是在消費級設備中，會降低臨床可靠性。頻繁充電會給患者帶來不便，並可能影響依從性。製造商面臨雙重挑戰：既要提高感測器精度，又要保持設備小巧的外形。儘管電池技術和感測器校準方面取得了進展，但這些挑戰仍然是穿戴式裝置廣泛應用的障礙。

人工智慧驅動的即時心率監測

持續監測需要設備長時間運作，但電池容量的限制往往導致頻繁充電。此外，數據準確性的波動，尤其是在消費級設備中，會降低臨床可靠性。患者可能覺得頻繁充電不便，進而影響順從性。製造商面臨雙重挑戰：既要提高感測器精度，也要保持設備緊湊的設計。儘管電池技術和感測器校準技術正在不斷進步，但這些挑戰仍然是設備廣泛應用的障礙。

資料隱私與網路安全風險

穿戴式心率監測設備會收集高度敏感的健康訊息，因此極易遭受資料外洩和未授權存取。遵守 HIPAA 和 GDPR 等國際法規進一步增加了其普及的難度。患者可能因為擔心個人健康數據被濫用而猶豫是否使用穿戴式裝置。一旦發生資料洩露，醫療機構也將面臨聲譽和法律風險。供應商正在投資加密技術、安全的雲端基礎設施和先進的身份驗證系統來降低這些風險。儘管採取了這些措施，網路安全問題仍然是推廣應用程式的一大障礙。

新型冠狀病毒（COVID-19）的影響：

新冠疫情加速了穿戴式心電圖監測設備的普及。隨著醫院不堪重負，面對面就診受到限制，遠端監測成為心臟病患者管理的關鍵。穿戴式裝置能夠持續追蹤心臟健康狀況，進而減少患者就醫次數。疫情期間，各國政府和醫療系統大力投資遠端醫療和遠距監測基礎設施。疫情凸顯了擴充性、以病人為中心的醫療技術在醫療服務中的重要性。後疫情時代，醫療機構將持續把穿戴式監測技術融入日常診療流程。

在預測期內，連續監測領域預計將佔據最大的市場佔有率。

隨著心血管疾病盛行率的上升，對持續心臟監測解決方案的需求日益成長，預計在預測期內，持續監測領域將佔據最大的市場佔有率。這些設備可提供心率、心率和其他重要參數的即時數據，從而實現異常情況的早期發現。醫院和診所越來越依賴持續監測來管理高風險患者。感測器技術和無線連接的進步正在提高設備的性能和可靠性。對於患者而言，這帶來了許多益處，例如更高的便利性和更少的就醫次數。透過與遠端醫療平台的整合，持續監測的效用得到了進一步提升。

預計在預測期內，基於人工智慧的分析領域將呈現最高的複合年成長率。

在預測期內，人工智慧分析領域預計將呈現最高的成長率，這主要得益於心血管疾病盛行率的不斷上升以及由此帶來的對預測性和個人化監測解決方案日益成長的需求。人工智慧演算法能夠分析大量的心臟數據，從而檢測心律不整、預測不利事件並提供針對特定患者的建議。醫生可受益於自動化警報和更高的診斷準確性。患者則可透過個人化見解和預防性照護獲得安心。此外，對數位健康和機器學習平台的投資增加也為該領域提供了支持。隨著醫療保健系統對人工智慧的廣泛應用，我們預計分析主導監測的普及率將大幅提升。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其先進的醫療保健基礎設施以及心血管疾病在總人口中日益成長的患病率。美國在穿戴式心電圖監測設備的核准方面處於主導地位，這得益於其完善的報銷體系和法規核准。市場主要企業總部均設在該地區，推動創新和商業化進程。心律不整、心臟衰竭和冠狀動脈疾病的高發生率推動了對持續監測的需求。人工智慧和數位健康平台與穿戴式裝置的深度融合也使該地區受益匪淺。持續加大研發投入和臨床試驗進一步鞏固了其市場領導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療保健的快速數位化以及新興經濟體心血管疾病盛行率的上升。中國、印度和東南亞等國家對價格合理且易於使用的監控解決方案的需求日益成長。各國政府正在投資醫療基礎設施並推廣遠端醫療計劃，以解決醫療保健方面的不平等問題。本土製造商提供成本績效的設備，從而促進了價格敏感型市場的普及。智慧型手機的普及和行動連線的改善正在加速穿戴式裝置與數位平台的融合。人們對預防性醫療保健意識的提高也進一步推動了市場擴張。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要企業進行SWOT分析（最多3家公司）
區域分類
- 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

Apple Inc.
Google（Fitbit）
Garmin Ltd.
Medtronic plc
Philips Healthcare
GE HealthCare
iRhythm Technologies Inc.
AliveCor Inc.
Preventice Solutions
Nihon Kohden Corporation
Omron Healthcare Inc.
Qardio Inc.
Withings SA
Biotronik SE & Co. KG
BioTelemetry Inc.
Abbott Laboratories

簡介目錄圖表

Product Code: SMRC35103

According to Stratistics MRC, the Global Wearable Cardiac Monitoring Devices Market is accounted for $14 billion in 2026 and is expected to reach $65 billion by 2034 growing at a CAGR of 21% during the forecast period. Wearable Cardiac Monitoring Devices are portable, body-worn technologies that continuously track heart-related parameters such as heart rate, rhythm, and electrical activity. These devices include smartwatches, patches, and portable ECG monitors that provide real-time data and alerts. They enable early detection of cardiac abnormalities, support chronic disease management, and improve patient engagement. Integration with mobile applications and healthcare systems allows remote monitoring by clinicians. Growing awareness of cardiovascular health and advancements in wearable technology are driving adoption of these devices globally.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular diseases

Rising cases of arrhythmias, heart failure, and coronary artery disease have intensified the need for continuous, accessible monitoring solutions. These devices provide real-time insights into heart rate, rhythm, and other vital parameters, enabling early detection of irregularities. Their portability and ease of use make them suitable for both hospital-based and home-based care. Healthcare providers are increasingly adopting wearables to improve patient outcomes and reduce hospital readmissions. With cardiovascular disease emerging as a global health burden, the demand for wearable monitoring solutions is expected to remain strong.

Restraint:

Limited battery life and device accuracy

Continuous monitoring requires devices to function for extended periods, yet limited battery capacity often necessitates frequent recharging. In addition, inconsistencies in data accuracy, particularly in consumer-grade devices, can reduce clinical confidence. Patients may find frequent charging inconvenient, which impacts compliance. Manufacturers face the dual challenge of improving sensor precision while maintaining compact designs. Although advancements in battery technology and sensor calibration are underway, these issues remain barriers to widespread adoption.

Opportunity:

AI-based real-time cardiac monitoring

Threat:

Data privacy and cybersecurity risks

The wearable cardiac monitoring devices collect sensitive health information, making them vulnerable to breaches and unauthorized access. Compliance with global regulations such as HIPAA and GDPR adds complexity to deployment. Patients may hesitate to adopt wearables if they fear misuse of personal health data. Healthcare providers also face reputational and legal risks in the event of breaches. Vendors are investing in encryption, secure cloud infrastructure, and advanced authentication systems to mitigate these risks. Despite these measures, cybersecurity concerns remain a persistent barrier to adoption.

Covid-19 Impact:

The COVID-19 pandemic accelerated the adoption of wearable cardiac monitoring devices. With hospitals overwhelmed and in-person consultations restricted, remote monitoring became critical for managing cardiac patients. Wearables enabled continuous tracking of heart health, reducing the need for hospital visits. Governments and healthcare systems invested heavily in telehealth and remote monitoring infrastructure during the crisis. The pandemic underscored the importance of scalable, patient-centric technologies in healthcare delivery. Even in the post-pandemic era, providers continue to integrate wearable monitoring into routine care.

The continuous monitoring segment is expected to be the largest during the forecast period

The continuous monitoring segment is expected to account for the largest market share during the forecast period as rising prevalence of cardiovascular diseases has intensified demand for uninterrupted cardiac tracking solutions. These devices provide real-time data on heart rate, rhythm, and other vital parameters, enabling early detection of abnormalities. Hospitals and clinics increasingly rely on continuous monitoring to manage high-risk patients. Advances in sensor technology and wireless connectivity are improving device performance and reliability. Patients benefit from enhanced convenience and reduced hospital visits. Integration with telehealth platforms further expands the utility of continuous monitoring.

The AI-based analytics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI-based analytics segment is predicted to witness the highest growth rate due to the rising prevalence of cardiovascular diseases, which has driven demand for predictive and personalized monitoring solutions. AI algorithms can analyze large volumes of cardiac data to detect arrhythmias, predict adverse events, and provide tailored recommendations. Physicians benefit from automated alerts and improved diagnostic accuracy. Patients gain confidence through personalized insights and proactive care. The segment is also supported by increasing investments in digital health and machine learning platforms. As healthcare systems embrace AI, adoption of analytics-driven monitoring is expected to surge.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to advanced healthcare infrastructure and the rising prevalence of cardiovascular diseases across the population. The U.S. leads in adoption of wearable cardiac monitoring devices, supported by strong reimbursement frameworks and regulatory approvals. Major players in the market are headquartered in the region, driving innovation and commercialization. High incidence of arrhythmia, heart failure, and coronary artery disease fuels demand for continuous monitoring. The region also benefits from strong integration of AI and digital health platforms with wearable devices. Ongoing investments in R&D and clinical trials further strengthen market leadership.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rapid healthcare digitization and the rising prevalence of cardiovascular diseases in emerging economies. Countries such as China, India, and Southeast Asia are witnessing increasing demand for affordable and accessible monitoring solutions. Governments are investing in healthcare infrastructure and promoting telehealth initiatives to improve equity. Local manufacturers are offering cost-effective devices, boosting adoption in price-sensitive markets. Growing smartphone penetration and mobile connectivity enhance integration of wearable devices with digital platforms. Rising awareness of preventive healthcare further supports market expansion.

Key players in the market

Some of the key players in Wearable Cardiac Monitoring Devices Market include Apple Inc., Google (Fitbit), Garmin Ltd., Medtronic plc, Philips Healthcare, GE HealthCare, iRhythm Technologies Inc., AliveCor Inc., Preventice Solutions, Nihon Kohden Corporation, Omron Healthcare Inc., Qardio Inc., Withings SA, Biotronik SE & Co. KG, BioTelemetry Inc. and Abbott Laboratories.

Key Developments:

In March 2026, Garmin introduced its Venu 3 smartwatch with enhanced ECG and heart rate variability monitoring. The device integrates with Garmin Connect for physician data sharing, expanding Garmin's footprint in regulated cardiac health tracking.

In September 2025, AliveCor expanded its KardiaMobile portfolio with FDA-cleared AI algorithms for early detection of atrial flutter and tachycardia. The device integrates with telehealth platforms, enabling patients to share ECG data directly with physicians. AliveCor continues to bridge consumer wearables with regulated cardiac diagnostics.

In June 2025, Apple expanded its Apple Watch health suite with FDA-cleared atrial fibrillation detection algorithms. The update integrates continuous ECG monitoring with AI-driven alerts, enabling early detection of irregular rhythms. Apple's innovation strengthens its role in consumer-driven cardiac monitoring, bridging lifestyle wearables with regulated medical-grade diagnostics.

Device Types Covered:

Holter Monitors
Event Monitors
ECG Patches
Smartwatches with ECG
Other Device Types

Monitoring Types Covered:

Continuous Monitoring
Intermittent Monitoring
Real-Time Monitoring
Remote Monitoring
Other Monitoring Types

Technologies Covered:

Electrocardiography (ECG)
Photoplethysmography (PPG)
AI-Based Analytics
Wireless Connectivity
Cloud-Based Monitoring
Other Technologies

Applications Covered:

Arrhythmia Detection
Heart Rate Monitoring
Stroke Prevention
Post-Surgical Monitoring
Other Applications

End Users Covered:

Hospitals
Cardiology Clinics
Home Care Settings
Ambulatory Surgical Centers
Fitness & Wellness Users
Other End Users

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Wearable Cardiac Monitoring Devices Market, By Device Type

5.1 Holter Monitors
5.2 Event Monitors
5.3 ECG Patches
5.4 Smartwatches with ECG
5.5 Other Device Types

6 Global Wearable Cardiac Monitoring Devices Market, By Monitoring Type

6.1 Continuous Monitoring
6.2 Intermittent Monitoring
6.3 Real-Time Monitoring
6.4 Remote Monitoring
6.5 Other Monitoring Types

7 Global Wearable Cardiac Monitoring Devices Market, By Technology

7.1 Electrocardiography (ECG)
7.2 Photoplethysmography (PPG)
7.3 AI-Based Analytics
7.4 Wireless Connectivity
7.5 Cloud-Based Monitoring
7.6 Other Technologies

8 Global Wearable Cardiac Monitoring Devices Market, By Application

8.1 Arrhythmia Detection
8.2 Heart Rate Monitoring
8.3 Stroke Prevention
8.4 Post-Surgical Monitoring
8.5 Other Applications

9 Global Wearable Cardiac Monitoring Devices Market, By End User

9.1 Hospitals
9.2 Cardiology Clinics
9.3 Home Care Settings
9.4 Ambulatory Surgical Centers
9.5 Fitness & Wellness Users
9.6 Other End Users

10 Global Wearable Cardiac Monitoring Devices Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiles

13.1 Apple Inc.
13.2 Google (Fitbit)
13.3 Garmin Ltd.
13.4 Medtronic plc
13.5 Philips Healthcare
13.6 GE HealthCare
13.7 iRhythm Technologies Inc.
13.8 AliveCor Inc.
13.9 Preventice Solutions
13.10 Nihon Kohden Corporation
13.11 Omron Healthcare Inc.
13.12 Qardio Inc.
13.13 Withings SA
13.14 Biotronik SE & Co. KG
13.15 BioTelemetry Inc.
13.16 Abbott Laboratories

簡介目錄圖表

List of Tables

Table 1 Global Wearable Cardiac Monitoring Devices Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Wearable Cardiac Monitoring Devices Market, By Device Type (2023-2034) ($MN)
Table 3 Global Wearable Cardiac Monitoring Devices Market, By Holter Monitors (2023-2034) ($MN)
Table 4 Global Wearable Cardiac Monitoring Devices Market, By Event Monitors (2023-2034) ($MN)
Table 5 Global Wearable Cardiac Monitoring Devices Market, By ECG Patches (2023-2034) ($MN)
Table 6 Global Wearable Cardiac Monitoring Devices Market, By Smartwatches with ECG (2023-2034) ($MN)
Table 7 Global Wearable Cardiac Monitoring Devices Market, By Other Device Types (2023-2034) ($MN)
Table 8 Global Wearable Cardiac Monitoring Devices Market, By Monitoring Type (2023-2034) ($MN)
Table 9 Global Wearable Cardiac Monitoring Devices Market, By Continuous Monitoring (2023-2034) ($MN)
Table 10 Global Wearable Cardiac Monitoring Devices Market, By Intermittent Monitoring (2023-2034) ($MN)
Table 11 Global Wearable Cardiac Monitoring Devices Market, By Real-Time Monitoring (2023-2034) ($MN)
Table 12 Global Wearable Cardiac Monitoring Devices Market, By Remote Monitoring (2023-2034) ($MN)
Table 13 Global Wearable Cardiac Monitoring Devices Market, By Other Monitoring Types (2023-2034) ($MN)
Table 14 Global Wearable Cardiac Monitoring Devices Market, By Technology (2023-2034) ($MN)
Table 15 Global Wearable Cardiac Monitoring Devices Market, By Electrocardiography (ECG) (2023-2034) ($MN)
Table 16 Global Wearable Cardiac Monitoring Devices Market, By Photoplethysmography (PPG) (2023-2034) ($MN)
Table 17 Global Wearable Cardiac Monitoring Devices Market, By AI-Based Analytics (2023-2034) ($MN)
Table 18 Global Wearable Cardiac Monitoring Devices Market, By Wireless Connectivity (2023-2034) ($MN)
Table 19 Global Wearable Cardiac Monitoring Devices Market, By Cloud-Based Monitoring (2023-2034) ($MN)
Table 20 Global Wearable Cardiac Monitoring Devices Market, By Other Technologies (2023-2034) ($MN)
Table 21 Global Wearable Cardiac Monitoring Devices Market, By Application (2023-2034) ($MN)
Table 22 Global Wearable Cardiac Monitoring Devices Market, By Arrhythmia Detection (2023-2034) ($MN)
Table 23 Global Wearable Cardiac Monitoring Devices Market, By Heart Rate Monitoring (2023-2034) ($MN)
Table 24 Global Wearable Cardiac Monitoring Devices Market, By Stroke Prevention (2023-2034) ($MN)
Table 25 Global Wearable Cardiac Monitoring Devices Market, By Post-Surgical Monitoring (2023-2034) ($MN)
Table 26 Global Wearable Cardiac Monitoring Devices Market, By Other Applications (2023-2034) ($MN)
Table 27 Global Wearable Cardiac Monitoring Devices Market, By End User (2023-2034) ($MN)
Table 28 Global Wearable Cardiac Monitoring Devices Market, By Hospitals (2023-2034) ($MN)
Table 29 Global Wearable Cardiac Monitoring Devices Market, By Cardiology Clinics (2023-2034) ($MN)
Table 30 Global Wearable Cardiac Monitoring Devices Market, By Home Care Settings (2023-2034) ($MN)
Table 31 Global Wearable Cardiac Monitoring Devices Market, By Ambulatory Surgical Centers (2023-2034) ($MN)
Table 32 Global Wearable Cardiac Monitoring Devices Market, By Fitness & Wellness Users (2023-2034) ($MN)
Table 33 Global Wearable Cardiac Monitoring Devices Market, By Other End Users (2023-2034) ($MN)